Clinical Trials Directory

Trials / Terminated

TerminatedNCT00515736

Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome

Influence Of Early Antioxidant Supplements On Clinical Evolution And Organ Function In Critically Ill Cardiac Surgery, Major Trauma And Subarachnoid Hemorrhage Patients

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Centre Hospitalier Universitaire Vaudois · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Critically ill patients are generally exposed to an increased oxidative stress, which is proportional to the severity of their condition. Endogenous antioxidant (AOX) defenses are depleted particularly in those patients with intense inflammatory response. The hypothesis tested is that early I:V: administration of a combination of AOX micronutrient supplements (Se, Zn, Vit C, Vit E, Vit B1) would improve clinical outcome in selected critically ill patients, by reinforcing the endogenous AOX defenses and reducing organ failure.

Detailed description

Prospective randomized, double-blind, placebo-controlled, single-center trial. Patients admitted to ICU after complicated cardiac surgery, major trauma with or without brain injury, subarachnoid hemorrhage, and predicted by the clinicians to require \>48 hours of ICU treatment. Supplements: provided IV for 5 days

Conditions

Interventions

TypeNameDescription
DRUGSelenium (Se), Zinc (Zn), Vitamin C, Vitamin B1, Vitamin ESe 270mcg, Zn 30mg, C 1.1g, B1 100mg, E 300mg
DRUGPlacebovehicle

Timeline

Start date
2003-01-01
Primary completion
2005-12-01
Completion
2005-12-01
First posted
2007-08-14
Last updated
2010-07-30

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00515736. Inclusion in this directory is not an endorsement.